Tags

Type your tag names separated by a space and hit enter

Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.
Clin Infect Dis 2010; 50(5):e30-3CI

Abstract

This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.

Authors+Show Affiliations

Department of Nephrology, Dialysis and Organ Transplantation, Centre Hospitalier Universitaire, Toulouse, France. kamar.n@chu-toulouse.frNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

20113176

Citation

Kamar, Nassim, et al. "Pegylated Interferon-alpha for Treating Chronic Hepatitis E Virus Infection After Liver Transplantation." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 50, no. 5, 2010, pp. e30-3.
Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010;50(5):e30-3.
Kamar, N., Rostaing, L., Abravanel, F., Garrouste, C., Esposito, L., Cardeau-Desangles, I., ... Izopet, J. (2010). Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 50(5), pp. e30-3. doi:10.1086/650488.
Kamar N, et al. Pegylated Interferon-alpha for Treating Chronic Hepatitis E Virus Infection After Liver Transplantation. Clin Infect Dis. 2010 Mar 1;50(5):e30-3. PubMed PMID: 20113176.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. AU - Kamar,Nassim, AU - Rostaing,Lionel, AU - Abravanel,Florence, AU - Garrouste,Cyril, AU - Esposito,Laure, AU - Cardeau-Desangles,Isabelle, AU - Mansuy,Jean Michel, AU - Selves,Janick, AU - Peron,Jean Marie, AU - Otal,Philippe, AU - Muscari,Fabrice, AU - Izopet,Jacques, PY - 2010/2/2/entrez PY - 2010/2/2/pubmed PY - 2010/4/16/medline SP - e30 EP - 3 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin. Infect. Dis. VL - 50 IS - 5 N2 - This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/20113176/full_citation L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/650488 DB - PRIME DP - Unbound Medicine ER -